Latest filing published 05 Jan 2011 for ROCK CREEK PHARMACEUTICALS, INC., €28k.
Insider track record
No signal scores available.
Leo S. Tonkin: trading record in brief
Leo S. Tonkin discloses dealings in Rock Creek Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 25 February 2009 to 4 January 2011, the count stands at 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 5 January 2011 with an option exercise (€28k) in Rock Creek Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Leo S. Tonkin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$0.74Common StockSEC:0001209191-11-001803:0
- 25,000 shares@ US$1.10Common StockSEC:0001181431-09-028701:0
- 50,000 shares@ US$2.00Common StockSEC:0001181431-09-012173:0
- 36,232 shares@ US$2.76Common StockSEC:0001181431-09-012173:1
4 of 4 declarations